The Pharma Accountability Project Names Naja Hall as President

Advocate and storyteller to lead national push for truth and transparency in health care ahead of high-stakes 2026 elections

New York, New York — The Pharma Accountability Project (TPAP), a grassroots initiative dedicated to exposing and challenging the financial influence of pharmaceutical companies over media and policy, today announced that Naja Hall has been appointed President of the organization.

Hall, a nationally recognized advocate and media voice known for her work in family and social justice, brings a sharp focus on truth-telling and transparency to TPAP’s growing platform. Her leadership marks the beginning of a new phase for the organization as it takes on one of the most underreported power structures in American life – the pharmaceutical industry’s hold over health policy and public perception.

“When I learned that my father’s doctor was giving him free drug samples straight from a pharmaceutical rep’s box, it hit me that this wasn’t actually about medicine – it was about marketing-driven health care decisions,” said Hall. “Patients deserve to be treated like people, not customers in a billion-dollar sales system. TPAP exists to make sure that truth, not profit, drives the stories Americans hear about their own health.”

Hall steps into her role as the nation moves toward what is projected to be the most expensive midterm election in history – one fueled in large part by pharmaceutical and health industry contributions. With billions of dollars already flowing into campaign coffers, TPAP plans to track how drug money influences both messaging and policymaking across parties.

Alec Alderson, TPAP Treasurer and board member, said the political backdrop makes Hall’s leadership especially timely.

“Naja brings both the conviction and discipline required to take on an industry this powerful,” Alec said. “As we head into an election year where pharmaceutical dollars will quietly shape debates about affordability and access, TPAP’s mission becomes even more urgent. She understands that accountability isn’t about attacking medicine – it’s about protecting people from manipulation. Her leadership ensures TPAP keeps pushing where others won’t.”

Democrats have shown they can mobilize voters on issues of health care affordability and fairness – and Republicans, many of whom campaigned on lowering costs and fighting corporate overreach, will face growing pressure to prove they’re standing up for patients, not donors.

Mike Holtzmann, TPAP board member and government affairs liaison, said the organization will be keeping a close eye on how both parties navigate that balance.

“Pharma’s influence over policy and media has gone unchecked for decades,” Holtzmann said. “Every election cycle, the same corporations that drive up drug prices bankroll both sides of the aisle. If Republicans want to win on health care, they need to show they’re fighting for affordable care and transparency – not carrying water for corporate interests. Our job is to make sure voters can see exactly who’s standing where.”

Under Hall’s direction, TPAP will expand its investigative and educational work, exposing stealth advertising and lobbying efforts, training Americans to spot pharmaceutical influence in everyday media, and advocating for reforms that put people before profit.

With Hall at the helm and a board united around reform, TPAP enters this next chapter with one goal: restoring truth, transparency, and accountability in an election cycle where the stakes couldn’t be higher.

About The Pharma Accountability Project (TPAP)

The Pharma Accountability Project is a grassroots initiative dedicated to restoring truth and transparency in American health care. TPAP investigates how pharmaceutical money shapes media narratives, policy decisions, and public perception – and works to expose the hidden systems that put profit before patients. Through education, advocacy, and accountability, TPAP empowers Americans to recognize and challenge undue corporate influence over their health and their democracy.